Theriva Biologics, Inc.TOVXNYSE
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
Year-over-Year Change
Price-to-earnings ratio
Latest
-0.09
↑ 100% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthElevated
Average
-37.61
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -0.09 | +75.6% |
| 2023 | -0.38 | -6.5% |
| 2022 | -0.35 | +99.4% |
| 2021 | -58.13 | -220.7% |
| 2020 | -18.13 | -33.1% |
| 2019 | -13.61 | -108.5% |
| 2018 | -6.53 | +93.9% |
| 2017 | -107.44 | -63.1% |
| 2016 | -65.89 | +37.6% |
| 2015 | -105.53 | - |